FDG-PET/CT 用于坏死性(恶性)外耳道炎的诊断与随访
该病例系列研究纳入2013至2017年经临床特征和颞骨FDG摄取阳性诊断的12例坏死性外耳道炎患者,评估18F-FDG-PET/CT用于诊断和判断治疗反应。结论认为该检查是诊断、病灶定位和决定停药可靠影像手段,应考虑作为初始诊断和随访的首选影像方式,但需更大规模对照研究。
要点
- 18F-FDG-PET/CT可定位颞骨骨髓炎,外耳道、乳突、颞下颌关节、鼻咽区阳性率分别为100%、50%、16%、8%。
- 8例(67%)在活动性炎症消退且抗生素治疗至少6周后复查PET/CT示FDG摄取无或明显减少,随后停药。
- 作者认为18F-FDG-PET/CT应考虑作为坏死性外耳道炎初始诊断和随访的首选影像方式。
核心结论
- 18F-FDG-PET/CT是诊断坏死性外耳道炎、定位病变及决定是否停用抗生素的可靠影像手段。
- 作者认为18F-FDG-PET/CT应考虑作为坏死性外耳道炎初始诊断和随访的首选影像方式。
- 作者指出需更大规模的对照研究。
研究设计与样本
- 研究设计为病例系列,共纳入12例患者。
- 研究在三级转诊中心进行,时间为2013年至2017年。
- 坏死性外耳道炎诊断依据临床特征及PET/CT示颞骨内FDG摄取阳性。
- 患者平均年龄74±11.5岁,83%为男性,83%患糖尿病。
- PET/CT图像由两名核医学专家独立审阅。
主要发现
- 影像定位骨髓炎位于外耳道、乳突、颞下颌关节和鼻咽区,分别占100%、50%、16%、8%。
- 平均随访16个月。
- 8例(67%)在活动性耳炎消退且抗生素治疗至少6周后行第二次PET/CT,示FDG摄取无或明显减少,随后停止治疗,随访结束时无坏死性外耳道炎症状。
- 1例FDG摄取明显,继续抗生素治疗直至第三次扫描示无FDG摄取。
- 2例在第二次PET/CT前死亡,2例失访。
临床怎么用
- 作者认为18F-FDG-PET/CT应考虑作为坏死性外耳道炎初始诊断和随访的首选影像方式。
- 在活动性炎症消退且抗生素治疗至少6周后,复查PET/CT示FDG摄取无或明显减少者可停止抗生素治疗。
- FDG摄取明显者继续抗生素治疗,直至复查扫描示无FDG摄取。
局限性
- 作者指出需更大规模的对照研究。
- 研究为病例系列,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Imaging is important for the diagnosis and follow-up of necrotizing external otitis (NEO). The best imaging modality is controversy. To suggest 2-deoxy-2-[fluorine-18] fluoro-D-glucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) as an alternative to technetium-99m and gallium-67 scans for diagnosis and assessment of response to treatment for patients with NEO. STUDY DESIGN: Case series. METHODS: Tertiary referral center. From 2013 through 2017, 12 patients were diagnosed with NEO based on clinical features and positive FDG uptake within the temporal bone on PET/CT. Mean age was 74 ± 11.5; 83% of the patients were male; and 83% had diabetes. RESULTS: PET/CT scans were reviewed independently by two nuclear medicine specialists. Imaging located osteomyelitis in external ear canal, mastoid, temporomandibular joint, and nasopharyngeal region (100%, 50%, 16%, 8%, respectively). Mean follow-up was 16 months. Eight patients (67%) underwent a second PET/CT scan after active otitis resolved and after at least 6 weeks of antibiotic treatment. The scan demonstrated no or substantially reduced FDG uptake and treatment was stopped. The patients had no NEO symptoms at the end of follow-up. One patient had significant uptake, and antibiotic treatment was continued until a third scan demonstrated no FDG uptake. Two patients died before the second PET/CT, and two were lost to follow-up. CONCLUSION: 18F-FDG-PET/CT is a reliable imaging modality for diagnosis, disease localization, and decision making regarding treatment cessation. 18F-FDG-PET/CT should be considered as the imaging modality of choice for initial diagnosis and follow-up in NEO patients. Larger, controlled studies are warranted. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:961-966, 2019.
引用
- Stern Shavit S, Bernstine H, Sopov V, et al. FDG-PET/CT for diagnosis and follow-up of necrotizing (malignant) external otitis. Laryngoscope. 2018. PMID: 30549258. doi:10.1002/lary.27526
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。